Tirzepatide
Public supplier report and marketplace listing from UWA Biotech.
Supplier testing information
Product overview
Tirzepatide is a dual GIP and GLP-1 pathway research peptide supplied by UWA Biotech for laboratory investigations involving metabolic signalling, incretin receptor activity, peptide pharmacology and advanced obesity and metabolic research applications.
Available formats
- 10 × 5mg
- 10 × 10mg
- 10 × 15mg
- 10 × 20mg
- 10 × 30mg
- 10 × 60mg
- MOQ: 10 vials / 1 box
Verification
- Purity: 99.688%
- Tested: 25 FEB 2026
- Task number: #110143
- Unique key: 5IVMYW1E5G18
Research applications
- GLP-1 pathway research
- GIP receptor investigations
- Metabolic signalling studies
- Incretin peptide research
This product is supplied exclusively for laboratory research use. Not for human consumption, therapeutic use or clinical application.
Tirzepatide laboratory testing questions
What is this Tirzepatide report?
This report contains publicly accessible batch testing information for Tirzepatide, including task number #110143, reported purity results, and Janoshik-linked laboratory reference data.
Has this Tirzepatide batch been laboratory tested?
Yes. This Tirzepatide batch includes publicly accessible laboratory testing references, including reported purity result 99.688%, task number #110143, and laboratory reference key 5IVMYW1E5G18.
Who supplied this Tirzepatide batch?
UWA Biotech supplied this Tirzepatide batch from United States, with public batch testing references and tracked supplier fulfilment information.
What purity was reported for this Tirzepatide batch?
The reported purity result for this Tirzepatide batch was 99.688%.
Where can I view additional Tirzepatide reports?
Additional Tirzepatide laboratory testing reports and supplier batch references can be viewed through the Buy China Peptides reports directory.